Investing.com-- Oil prices steadied in Asian trade on Wednesday after rising over 4% in the prior session as the Israel-Iran conflict pushed up fears of supply disruptions, while industry data showed ...

Investing.com-- U.S. stock futures ticked down on Tuesday evening after Wall Street closed modestly lower, as the ongoing ...

Tokyo is racing to reach a trade deal with the U.S. in order to stem further export weakness. But there appears to be limited ...

The bill, called the GENIUS Act, was backed by both Democrats and Republicans and approved in a 68-30 vote. The bill will now ...

The review includes U.S. Steel’s Ba3 corporate family rating, Ba3-PD probability of default rating, and B1 senior unsecured debt rating. Big River Steel LLC’s Ba2 secured debt rating was also placed ...

Investing.com -- S&P Global Ratings revised its outlook on Ladder Capital (NYSE: LADR) Finance Holdings LLLP to positive from stable on Tuesday, while affirming the company’s ’BB’ long-term issuer ...

Investing.com -- Iran has prepared missiles and military equipment for potential strikes on U.S. bases in the Middle East if the United States joins Israel’s war against the country, according to the ...

Investing.com -- Moody’s Ratings has upgraded Johnson Controls (NYSE: JCI) International plc’s senior unsecured ratings to Baa1 from Baa2 while affirming its P-2 commercial paper program ratings. The ...

Investing.com -- S&P Global Ratings has assigned the United Arab Emirates (UAE) an ’AA/A-1+’ long and short-term foreign and local currency sovereign credit rating with a stable outlook.

S&P expects annual revenue growth in the aftermarket segment to moderate to the low- to mid-single-digit range as Bombardier maintains 50%-52% share of its addressable market and leverages its large ...

Investing.com -- Generation Essentials Group (NYSE: TGE) stock closed higher by 49.9% following the announcement of significant strides in the entertainment sector with multiple upcoming movie ...

Investing.com -- CERo Therapeutics Holdings Inc (NASDAQ: CERO) stock surged 191.6% after the U.S. Food and Drug Administration (FDA) granted Orphan Drug Designation (ODD) for the company’s lead drug ...